393 related articles for article (PubMed ID: 7694215)
21. Fetal malformation and serum alpha-fetoprotein concentration of diabetic mothers.
Szabó M; Tóth T; Tóth Z; Szeifert GT; Csécsei K; Veress L; Papp Z
Zentralbl Gynakol; 1986; 108(20):1228-36. PubMed ID: 2433853
[TBL] [Abstract][Full Text] [Related]
22. Fetal anomaly scan potentially will replace routine AFAFP assays for the detection of neural tube defects.
Kooper AJ; de Bruijn D; van Ravenwaaij-Arts CM; Faas BH; Creemers JW; Thomas CM; Smits AP
Prenat Diagn; 2007 Jan; 27(1):29-33. PubMed ID: 17154227
[TBL] [Abstract][Full Text] [Related]
23. A normal ultrasound does not obviate the need for amniocentesis in patients with elevated serum alpha-fetoprotein.
Drugan A; Zador IE; Syner FN; Sokol RJ; Sacks AJ; Evans MI
Obstet Gynecol; 1988 Oct; 72(4):627-30. PubMed ID: 2458560
[TBL] [Abstract][Full Text] [Related]
24. Trisomy 18 and maternal serum and amniotic fluid alpha-fetoprotein.
Lindenbaum RH; Ryynänen M; Holmes-Siedle M; Puhakainen E; Jonasson J; Keenan J
Prenat Diagn; 1987 Sep; 7(7):511-9. PubMed ID: 2444965
[TBL] [Abstract][Full Text] [Related]
25. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
[TBL] [Abstract][Full Text] [Related]
26. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
27. Prenatal diagnosis in diabetic gravidas: utility of ultrasound and maternal serum alpha-fetoprotein screening.
Greene MF; Benacerraf BR
Obstet Gynecol; 1991 Apr; 77(4):520-4. PubMed ID: 1706079
[TBL] [Abstract][Full Text] [Related]
28. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities.
Stiller RJ; de Regt RH; Suntag S; Baumgarten A; Hobbins JC; Mahoney MJ
Obstet Gynecol; 1990 Jun; 75(6):994-7. PubMed ID: 1692983
[TBL] [Abstract][Full Text] [Related]
29. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
[TBL] [Abstract][Full Text] [Related]
30. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
[TBL] [Abstract][Full Text] [Related]
31. Risks associated with an elevated amniotic fluid alpha-fetoprotein level.
Crandall BF; Matsumoto M
Am J Med Genet; 1991 Apr; 39(1):64-7. PubMed ID: 1714237
[TBL] [Abstract][Full Text] [Related]
32. Early pregnancy screening for neural tube defects in Israel.
Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
[TBL] [Abstract][Full Text] [Related]
33. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
Warner AA; Pettenati MJ; Burton BK
Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
[TBL] [Abstract][Full Text] [Related]
34. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
Huttly W; Rudnicka A; Wald NJ
Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
[TBL] [Abstract][Full Text] [Related]
35. Congenital nephrosis as a cause of elevated alpha-fetoprotein.
Albright SG; Warner AA; Seeds JW; Burton BK
Obstet Gynecol; 1990 Nov; 76(5 Pt 2):969-71. PubMed ID: 1699188
[TBL] [Abstract][Full Text] [Related]
36. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
37. [Hydramnios and fetal malformations. Use of estimating the level of alpha-fetoprotein and of bilirubin in the amniotic fluid during the last trimester of pregnancy (author's transl)].
Henrion R; Herbinet E; Cédard L; Dallot E; Sender A; Rouvillois JL
J Gynecol Obstet Biol Reprod (Paris); 1978; 7(7):1207-19. PubMed ID: 84825
[TBL] [Abstract][Full Text] [Related]
38. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
39. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Wald NJ; Watt HC; George L
Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061
[TBL] [Abstract][Full Text] [Related]
40. [Disorders of fetoplacental function in pregnant women with diabetes].
Mikulíková L; Struplová J; Fialová L; Malbohan I
Sb Lek; 1993; 94(2):173-7. PubMed ID: 7527583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
